- Home
- IMCR vs IART Comparison
IMCR vs IART Comparison
Compare IMCR & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- IART
- Stock Information
- Founded
- IMCR 2008
- IART 1989
- Country
- IMCR United Kingdom
- IART United States
- Employees
- IMCR N/A
- IART N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- IART Medical/Dental Instruments
- Sector
- IMCR Health Care
- IART Health Care
- Exchange
- IMCR Nasdaq
- IART Nasdaq
- Market Cap
- IMCR 1.5B
- IART 1.7B
- IPO Year
- IMCR 2021
- IART 1995
- Fundamental
- Price
- IMCR $29.92
- IART $21.13
- Analyst Decision
- IMCR Buy
- IART Sell
- Analyst Count
- IMCR 13
- IART 7
- Target Price
- IMCR $65.18
- IART $24.67
- AVG Volume (30 Days)
- IMCR 158.6K
- IART 489.3K
- Earning Date
- IMCR 02-26-2025
- IART 02-25-2025
- Dividend Yield
- IMCR N/A
- IART N/A
- EPS Growth
- IMCR N/A
- IART N/A
- EPS
- IMCR N/A
- IART N/A
- Revenue
- IMCR $296,312,000.00
- IART $1,564,920,000.00
- Revenue This Year
- IMCR $28.89
- IART $6.71
- Revenue Next Year
- IMCR $13.00
- IART $6.20
- P/E Ratio
- IMCR N/A
- IART N/A
- Revenue Growth
- IMCR 25.09
- IART 1.45
- 52 Week Low
- IMCR $27.69
- IART $16.81
- 52 Week High
- IMCR $72.56
- IART $45.09
- Technical
- Relative Strength Index (RSI)
- IMCR 47.96
- IART 27.91
- Support Level
- IMCR $28.41
- IART $23.67
- Resistance Level
- IMCR $30.49
- IART $24.69
- Average True Range (ATR)
- IMCR 1.47
- IART 0.89
- MACD
- IMCR -0.07
- IART -0.57
- Stochastic Oscillator
- IMCR 41.03
- IART 0.68
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.